PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.50%
Negative net income growth while AVGO stands at 46.71%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.51%
Some D&A expansion while AVGO is negative at -0.82%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
21.57%
Lower deferred tax growth vs. AVGO's 75.20%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
3.10%
Less SBC growth vs. AVGO's 16.99%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-1428.57%
Negative yoy working capital usage while AVGO is 206.25%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-889.29%
AR is negative yoy while AVGO is 183.82%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-14550.00%
Both reduce yoy inventory, with AVGO at -20.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
581.82%
AP growth well above AVGO's 117.75%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
250.96%
Some yoy usage while AVGO is negative at -298.80%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-75.00%
Both negative yoy, with AVGO at -122.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-36.82%
Negative yoy CFO while AVGO is 25.09%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-9.32%
Both yoy lines negative, with AVGO at -26.26%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
7.21%
Purchases growth of 7.21% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
915.44%
Liquidation growth of 915.44% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
80.31%
Less 'other investing' outflow yoy vs. AVGO's 66966.67%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
77.33%
Investing outflow well above AVGO's 99.30%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment above 1.5x AVGO's 34.88%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
89.92%
Repurchase growth 1.25-1.5x AVGO's 62.14%. Bruce Berkowitz would confirm if the firm invests enough in expansions while boosting EPS.